The effects of captopril (Cap) and verapamil (Ver) alone and in combination on intracellular Na 
INTRODUCTION
Vascular smooth muscle cells possess a number of Na + transport systems, namely Na + channels, Na + -Ca 2+ , Na + -H + exchange, and Na + -K + -2C1 -co-transport [1] .
Hypothesized roles for these systems include regulation of vascular tone, cell volume and cell proliferation. In both experimental and human hypertension aberrations in smooth muscle cell, univalent ion transport system play an important role in the pathogenesis and maintenance of hypertension [2] . Angiotensin-converting enzyme (ACE) inhibitors and Ca 2+ antagonists are widely used for the treatment of hypertension. The combination of both drugs produces a larger hypotensive effect than either drug given alone. However, the mechanisms of this synergistic effect is not well known. The effects of both drugs on Ca 2+ fluxes mediated by agonists in vascular smooth muscle cells, which are associated with Na + transport [3] have been studied [4, 5] . But there is scant information as to the the effects of both drugs on Na + regulation.
The purpose of the present study was to evaluate the effect of ACE inhibitor captopril (Cap) and Ca 2+ antagonist verapamil (Ver) alone and in combination on angiotensin (Ang-II)-induced changes in intracellular Na + ([Na + ] i ) in aortic smooth muscle cells (ASMC).
MATERIALS AND METHODS
Sodium-binding benzofuran isophthalate (SBFI)/acetoxymethyl ester(AM) and SBFI was from Sigma. Ang-II was from Sigma. Cap was obtained from Chang Zhou Pharmaceutical Factory, Ver from Shanghai Tian-Ping Pharmaceutical Factory. Mouse anti-human actin and sheep anti-mouse IgG/FITC were purchased from Sino-American Biotechnolgy Co. Medium-199 was from Nissui. Pluronic F-127 and Me 2 SO were purchased from Sigma.
Cell culture Passages 9-11 ASMC derived from thoracic aortae of rabbits were cultured as described previously [4] . Immunocytochemical characterization of ASMC was performed using monoclonal antibodies mouse anti-human actin against smooth muscle-specific α-actin [6] . Cultured ASMC showed positive staining for α-actin with a fluorescence marker sheep anti-mouse IgG/FITC. For the experiments, the cells were grown on thin glass coverslips at a density of (1-5) ×10 5 /ml. 2 d later, the medium was aspirated and the cells were made quiescent by incubation in Medium-199 containing 0.1% bovine serum albumin and indicated concentration of Cap and Ver for 48 h before the studies.
[Na + ]i change was assessed 6-7 h after the exposure to Ang-II.
Fluorescent dye loading
Cell-grown cover slips were rinsed twice with HEPES-buffered solution (HBS) (mmol/L: NaCl 1, KCl 5.4 CaCl2 1.2, MgCl2 1.2, HEPES 10, glucose 5) and loaded for 2 h at 37 ℃ in same HBS containing 5μmol/L SBFI/AM dispersed with 0.2 % Pluronic F-127, a nonionic surfactant. After loading, the cells on cover slips were superfused for 10 min twice with HBS, and then transferred to a tissue chamber mounted on a microscope stage.
Digital imaging methods and image analysis SBFI fluorescence (500 nm emission excited by 340 nm illumination) from the cells was imaged Captopril or verapamil on [Na + ] i in vascular smooth muscle cells using a Nikon UV-Fluor objective. The fluoresent images were recorded by photograph (Fig 1) . 
Statistics
Data are represented as x ± s of 40 cells of 4 rabbits, 10 cells/rabbit (as one group). Unpaired t -test was used to test the significance of the data. When the differences between group means were evaluated by analysis of multiple variance, it was found to be statistically not significant. (Fig 3) . 
DISCUSSION
In the present study, [Na + ]i was measured with SBFI, monitored by digital imaging fluorescent microscope at a single-cell level and estimated with in vitro calibration protocol. The mean basal [Na + ]i determined in ASMC was 11.9 mmol/L. This value is closed to 13 mmol/L reported by Okada et al [3] which was measured in cuvette for SBFI-loaded rat aorta smooth muscle cells. When the resting cells were exposed to Ang-II for 7 h, a concentration-dependent increase in [Na + ]i was seen.
In the presence of Ver (0.1 to 10 μmol/L), this increase in [Na + ]i was prevented.
Clinical data showed that oral application of Ver and ditiazem caused a decrease in [Na + ]i in the leukocyte and erythrocyte of hypertensive patients [7, 8] We also found that Cap enhanced Ang-II-induced increase in [Na + ]i at 10 μmol/L but not at 0.1-1 μmol/L. Accetto et al [9] demonstrated that Cap produced inhibition of K + -induced relaxation of rat tail artery. In the study of Unger et al [10] , a significant initial pressor effect was observed when Cap was delivered into the lateral cerebral ventricles of stroke-prone spontaneously hypertensive or Wistar-Kyoto control rats. Therefore, these findings suggested that an increase in Therefore, these results may provide a new hypothesis for the underlying molecular mechanism of synergistic effect of the combination of Ca 2+ antagonists and angiotensin-converting enzyme inhibitors in controlling blood pressure.
